/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
/f/125658/4252x1496/43d16b540f/ehra-acronym-name-rgb.png)
Dr. Léna Rivard obtained her medical degree from the University of Lariboisière, Paris and has two Master’s degrees (Clinical Research Methods and Biostatistics).
In 2010, Dr. Rivard was recruited as a staff electrophysiologist and clinician investigator at the Montreal Heart Institute. Her speciality is in the domain of complex catheter ablation procedures. She is the principal investigator of two ongoing multicenter studies: the BRAIN-AF trial funded by the Canadian Stroke Prevention Network (C-SPIN), the Montreal Heart Institute Foundation and BAYER global and the COME-TAVI trial funded by the Heart and Stroke Foundation of Canada. Dr. Rivard also received research salary support from the FRSQ (Fonds recherche en sante du Quebec).
Changes in Cognitive Function in Patients with Subclinical Atrial Fibrillation Treated with Apixaban or Aspirin: A Sub-Study from the ARTESiA Trial
Event: ESC Congress 2024
Topic: Cognitive Function and Autonomy in Patients with Atrial Fibrillation
Session: Smaller trials, trial updates, and other studies on antiplatelet and antithrombotic therapies
